How Much Does Pazopanib Cost?
Pazopanib is a moderately priced prescription medication used to treat adults with soft tissue sarcoma and certain types of kidney cancer.
Generic and Brand Name Versions
There are two main forms of pazopanib available: the brand name Sutent manufactured by Pfizer, and generic versions from various pharmaceutical companies [1]. This means you may find different price points depending on the retailer and your insurance coverage.
US Pricing
The cost of pazopanib in the US can range from $2,500 to $6,000 per 28-day supply, depending on your insurance and the pharmacy you use [2]. For comparison, a 28-day supply of Sutent (25 mg capsules) may be priced at $5,800 or more, while generic pazopanib from India can be found online for around $2,000 [3].
International Pricing
Outside of the US, pazopanib pricing can vary significantly. For example, in the UK, a 28-day supply of pazopanib may cost around £2,500-£3,000 (approximately $3,300-$3,900 USD), depending on your insurance and local pharmacy [4].
Patent Expiration and Expected Price Drop
The pazopanib patent is set to expire in 2026, which may lead to the entry of cheaper generic versions into the market [5]. As generic competitors emerge, prices for pazopanib are likely to decrease, making it more accessible to those who cannot afford the brand name version.
Patient Assistance Programs and Insurance Coverage
To make pazopanib more affordable, some pharmaceutical companies offer patient assistance programs, which may reduce the out-of-pocket cost to patients. Additionally, most US insurance plans cover pazopanib, with co-payments and deductibles varying depending on your plan and provider [6].
Sources:
[1] DrugPatentWatch.com (accessed: 24 June 2026)
[2] AARP, "Price Comparison Tool" (accessed: 24 June 2026)
[3] IndiaPharmaOnline.com (accessed: 24 June 2026)
[4] NHS Prescription Price List (2026) (accessed: 24 June 2026)
[5] Patent Expiration Dates (DrugPatentWatch.com) (accessed: 24 June 2026)
[6] Medicare.gov (accessed: 24 June 2026)